The bioavailability of the novel nonnucleoside reverse transcriptase inhibitor GW420867X is unaffected by food in healthy male volunteers. [electronic resource]
Producer: 20011101Description: 528-35 p. digitalISSN:- 0091-2700
- Adult
- Area Under Curve
- Biological Availability
- Confidence Intervals
- Cross-Over Studies
- Dietary Fats
- Food-Drug Interactions
- Gastrointestinal Diseases -- chemically induced
- Half-Life
- Headache -- chemically induced
- Humans
- Least-Squares Analysis
- Male
- Metabolic Clearance Rate
- Middle Aged
- Quinoxalines -- adverse effects
- Reverse Transcriptase Inhibitors -- adverse effects
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.